Quantcast
Insmed Incorporated (NASDAQ: INSM) | The Mesh Report

Insmed Incorporated (NASDAQ: INSM)

Christian Tharp, CMT November 15, 2019 Comments Off on Insmed Incorporated (NASDAQ: INSM)

Insmed Incorporated, a global biopharmaceutical company, focuses on the development and commercialization of therapies for patients with serious and rare diseases.

Take a look at the 1-year chart of Insmed (NASDAQ: INSM) below with my added notations:

INSM has hit the $20 mark (red) as resistance multiple twice over the past couple of months. The stock has made it close to that level once again and could be looking to finally break higher. A solid close above $20 should lead to much higher prices for INSM.

The Tale of the Tape: INSM has a key level of resistance at $20. A long trade could be entered on a hold above that level. However, if you are bearish on the stock, a short trade could be made on any rallies up to $20.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!

Good luck!
Christian Tharp, CMT



Comments are closed.